We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.
| Share Name | Share Symbol | Market | Type |
|---|---|---|---|
| Endo International PLC | NASDAQ:ENDP | NASDAQ | Common Stock |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.00% | 0.2926 | 0.29 | 0.294 | 0 | 01:00:00 |
From May 2019 to May 2024
Endo Health Solutions Inc. (ENDP) is in talks with drug makers about selling itself, Reuters reported, citing people familiar with the matter.
Shares were recently 9% higher at $31.23 after tripping a single-stock circuit breaker. The stock is down 13% over the last 12 months.
The exploratory talks include Warner Chilcott PLC (WCRX) and Valeant Pharmaceuticals International Inc. (VRX, VRX.T), but there is no official auction process underway and discussions are at a preliminary stage, according to the report.
A representative for Endo declined to comment to Dow Jones, while Warner Chilcott and Valeant didn't immediately respond to requests for comment.
Earlier this month, Endo Health lowered its 2013 guidance, saying it expects higher charges related to its core painkiller franchise and generic-drug business.
Full story: http://www.reuters.com/article/2013/01/30/us-endohealth-sale-idUSBRE90T19020130130
Write to Hot Stocks at hotstocks@dowjones.com
Subscribe to WSJ: http://online.wsj.com?mod=djnwires
1 Year Endo Chart |
1 Month Endo Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
